$RDVT

Red Violet, Inc.

No enriched coverage for $RDVT in the last 7 days.

No SEC Form 4 filings for $RDVT in the last 30 days.

Med

Red Violet (RDVT) director gets 1,857 RSU award for Audit Committee role

Red Violet, Inc. director Greg Strakosch received a grant of 1,857 restricted stock units (RSUs) on March 2, 2026, for his appointment to the company's Audit Committee. These RSUs convert to common stock on a one-for-one basis and will vest over three years. Following this grant, Strakosch beneficially owns a total of 5,867 shares and RSUs, including previous grants from 2025.

Red Violet extends executive employment agreements through March 2030 By Investing.com

Red Violet, Inc. announced the extension of employment agreements for four key executives, including CEO Derek Dubner, President James Reilly, CFO Daniel MacLachlan, and CIO Jeffrey Dell. The new agreements now run through March 31, 2030, an extension from the previous March 26, 2027 expiration. This news follows Red Violet's strong third-quarter 2025 financial results, which reported record revenue and profit figures.